Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients.

MLA

Zinzani, Pier Luigi, et al. “Fludarabine-Mitoxantrone-Rituximab Regimen in Untreated Indolent Non-Follicular Non-Hodgkin’s Lymphoma: Experience on 143 Patients.” Hematological Oncology, vol. 33, no. 3, Sept. 2015, pp. 141–46. EBSCOhost, https://doi.org/10.1002/hon.2151.

APA

Zinzani, P. L., Pellegrini, C., Broccoli, A., Gandolfi, L., Stefoni, V., Casadei, B., Maglie, R., Argnani, L., & Pileri, S. (2015). Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin’s lymphoma: experience on 143 patients. Hematological Oncology, 33(3), 141–146. https://doi.org/10.1002/hon.2151

Chicago

Zinzani, Pier Luigi, Cinzia Pellegrini, Alessandro Broccoli, Letizia Gandolfi, Vittorio Stefoni, Beatrice Casadei, Roberto Maglie, Lisa Argnani, and Stefano Pileri. 2015. “Fludarabine-Mitoxantrone-Rituximab Regimen in Untreated Indolent Non-Follicular Non-Hodgkin’s Lymphoma: Experience on 143 Patients.” Hematological Oncology 33 (3): 141–46. doi:10.1002/hon.2151.